SEK88.10
0.17% yesterday
Stockholm, Oct 01, 05:30 pm CET
ISIN
SE0014428512
Symbol
SUS

Surgical Science Sweden AB Target price 2025 - Analyst rating & recommendation

Surgical Science Sweden AB Classifications & Recommendation:

Buy
75%
Hold
25%

Surgical Science Sweden AB Price Target

Target Price SEK181.05
Price SEK88.10
Potential
Number of Estimates 6
6 Analysts have issued a price target Surgical Science Sweden AB 2026 . The average Surgical Science Sweden AB target price is SEK181.05. This is higher than the current stock price. The highest price target is
SEK215.25 144.32%
register free of charge
, the lowest is
SEK121.20 37.57%
register free of charge
.
A rating was issued by 8 analysts: 6 Analysts recommend Surgical Science Sweden AB to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Surgical Science Sweden AB stock has an average upside potential 2026 of . Most analysts recommend the Surgical Science Sweden AB stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million SEK 884.09 1,072.00
0.14% 21.25%
EBITDA Margin 22.95% 19.44%
16.68% 15.28%
Net Margin 14.89% 11.15%
43.81% 25.12%

5 Analysts have issued a sales forecast Surgical Science Sweden AB 2025 . The average Surgical Science Sweden AB sales estimate is

SEK1.1b
Unlock
. This is
13.65% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
SEK1.1b 19.16%
Unlock
, the lowest is
SEK1.0b 9.73%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 SEK884m 0.14%
2025
SEK1.1b 21.25%
Unlock
2026
SEK1.3b 20.43%
Unlock
2027
SEK1.5b 18.90%
Unlock
2028
SEK1.9b 21.04%
Unlock
2029
SEK2.2b 16.47%
Unlock

5 Analysts have issued an Surgical Science Sweden AB EBITDA forecast 2025. The average Surgical Science Sweden AB EBITDA estimate is

SEK208m
Unlock
. This is
15.14% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
SEK222m 22.81%
Unlock
, the lowest is
SEK197m 8.82%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 SEK203m 16.56%
2025
SEK208m 2.73%
Unlock
2026
SEK388m 86.32%
Unlock
2027
SEK546m 40.60%
Unlock
2028
SEK916m 67.76%
Unlock

EBITDA Margin

2024 22.95% 16.68%
2025
19.44% 15.28%
Unlock
2026
30.08% 54.73%
Unlock
2027
35.57% 18.25%
Unlock
2028
49.30% 38.60%
Unlock

5 Surgical Science Sweden AB Analysts have issued a net profit forecast 2025. The average Surgical Science Sweden AB net profit estimate is

SEK120m
Unlock
. This is
29.33% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
SEK130m 40.26%
Unlock
, the lowest is
SEK112m 21.17%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 SEK132m 43.73%
2025
SEK120m 9.18%
Unlock
2026
SEK256m 114.38%
Unlock
2027
SEK379m 47.72%
Unlock
2028
SEK648m 71.07%
Unlock

Net Margin

2024 14.89% 43.81%
2025
11.15% 25.12%
Unlock
2026
19.85% 78.03%
Unlock
2027
24.67% 24.28%
Unlock
2028
34.86% 41.31%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share SEK 2.58 2.34
43.79% 9.30%
P/E 37.53
EV/Sales 3.64

5 Analysts have issued a Surgical Science Sweden AB forecast for earnings per share. The average Surgical Science Sweden AB EPS is

SEK2.34
Unlock
. This is
29.28% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
SEK2.54 40.33%
Unlock
, the lowest is
SEK2.20 21.55%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 SEK2.58 43.79%
2025
SEK2.34 9.30%
Unlock
2026
SEK5.02 114.53%
Unlock
2027
SEK7.42 47.81%
Unlock
2028
SEK12.69 71.02%
Unlock

P/E ratio

Current 48.59 48.65%
2025
37.53 22.76%
Unlock
2026
17.51 53.34%
Unlock
2027
11.85 32.32%
Unlock
2028
6.93 41.52%
Unlock

Based on analysts' sales estimates for 2025, the Surgical Science Sweden AB stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.14 39.83%
2025
3.64 12.07%
Unlock
2026
3.02 16.96%
Unlock
2027
2.54 15.90%
Unlock
2028
2.10 17.38%
Unlock
2029
1.80 14.14%
Unlock

P/S ratio

Current 4.78 37.73%
2025
4.21 12.01%
Unlock
2026
3.49 16.96%
Unlock
2027
2.94 15.90%
Unlock
2028
2.43 17.39%
Unlock
2029
2.08 14.14%
Unlock

Current Surgical Science Sweden AB Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BERENBERG
Locked
Locked
Locked Sep 01 2025
PARETO SECURITIES AS
Locked
Locked
Locked Aug 25 2025
BERENBERG
Locked
Locked
Locked Jul 01 2025
BERENBERG
Locked
Locked
Locked Jun 30 2025
PARETO SECURITIES AS
Locked
Locked
Locked May 16 2025
PARETO SECURITIES AS
Locked
Locked
Locked May 15 2025
DNB CARNEGIE
Locked
Locked
Locked Apr 17 2025
Analyst Rating Date
Locked
BERENBERG:
Locked
Locked
Sep 01 2025
Locked
PARETO SECURITIES AS:
Locked
Locked
Aug 25 2025
Locked
BERENBERG:
Locked
Locked
Jul 01 2025
Locked
BERENBERG:
Locked
Locked
Jun 30 2025
Locked
PARETO SECURITIES AS:
Locked
Locked
May 16 2025
Locked
PARETO SECURITIES AS:
Locked
Locked
May 15 2025
Locked
DNB CARNEGIE:
Locked
Locked
Apr 17 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today